TY - JOUR
T1 - The Electrically Evoked Auditory Change Complex Evoked by Temporal Gaps Using Cochlear Implants or Auditory Brainstem Implants in Children with Cochlear Nerve Deficiency
AU - He, Shuman
AU - McFayden, Tyler C.
AU - Shahsavarani, Bahar S.
AU - Teagle, Holly F.B.
AU - Ewend, Matthew
AU - Henderson, Lillian
AU - Buchman, Craig A.
N1 - Funding Information:
Supported in parts by the R03 from NIH/NIDCD (1R03DC013153) and the R01 grants from NIH/NIDCD and NIH/NIGMS (1R01DC016038), funding provided by the Wheatherspoon family, and the pilot grant of Center for Perception and Communication in Children (COBRE) NIH/NIGMS (5P20 GM109023-03). S1–S4 were enrolled in the Food and Drug Administration (FDA) approved clinical trial entitled “An Early Feasibility Study of the Safety and Efficacy of the Nucleus 24 Auditory Brainstem Implant in Children with Cochlear or Cochlear Nerve Disorder Not Resulting from Neurofibromatosis Type II” (approval number: IDE G120099). Cochlear Corp. generously donated Cochlear Nucleus 24M ABIs for this clinical trial.
Funding Information:
The authors would like to thank all study participants and their parents for participating in this study. We also gratefully thank reviewers for their insightful comments. Supported in parts by the R03 from NIH/NIDCD (1R03DC013153) and the R01 grants from NIH/NIDCD and NIH/NIGMS (1R01DC016038), funding provided by the Wheatherspoon family, and the pilot grant of Center for Perception and Communication in Children (COBRE) NIH/NIGMS (5P20 GM109023-03). S1?S4 were enrolled in the Food and Drug Administration (FDA) approved clinical trial entitled ?An Early Feasibility Study of the Safety and Efficacy of the Nucleus 24 Auditory Brainstem Implant in Children with Cochlear or Cochlear Nerve Disorder Not Resulting from Neurofibromatosis Type II? (approval number: IDE G120099). Cochlear Corp. generously donated Cochlear Nucleus 24M ABIs for this clinical trial. Craig A. Buchman is a member of Cochlear Corp. Surgeon?s Advisory Board and Holly F.B. Teagle is a member of a Cochlear Corp. Audiology Advisory Board.
Publisher Copyright:
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved
PY - 2018/5/1
Y1 - 2018/5/1
N2 - Objectives: This study aimed to (1) establish the feasibility of measuring the electrically evoked auditory change complex (eACC) in response to temporal gaps in children with cochlear nerve deficiency (CND) who are using cochlear implants (CIs) and/or auditory brainstem implants (ABIs); and (2) explore the association between neural encoding of, and perceptual sensitivity to, temporal gaps in these patients. Design: Study participants included 5 children (S1 to S5) ranging in age from 3.8 to 8.2 years (mean: 6.3 years) at the time of testing. All subjects were unilaterally implanted with a Nucleus 24M ABI due to CND. For each subject, two or more stimulating electrodes of the ABI were tested. S2, S3, and S5 previously received a CI in the contralateral ear. For these 3 subjects, at least two stimulating electrodes of their CIs were also tested. For electrophysiological measures, the stimulus was an 800-msec biphasic pulse train delivered to individual electrodes at the maximum comfortable level (C level). The electrically evoked responses, including the onset response and the eACC, were measured for two stimulation conditions. In the standard condition, the 800-msec pulse train was delivered uninterrupted to individual stimulating electrodes. In the gapped condition, a temporal gap was inserted into the pulse train after 400 msec of stimulation. Gap durations tested in this study ranged from 2 up to 128 msec. The shortest gap that could reliably evoke the eACC was defined as the objective gap detection threshold (GDT). For behavioral GDT measures, the stimulus was a 500-msec biphasic pulse train presented at the C level. The behavioral GDT was measured for individual stimulating electrodes using a one-interval, two-alternative forced-choice procedure. Results: The eACCs to temporal gaps were recorded successfully in all subjects for at least one stimulating electrode using either the ABI or the CI. Objective GDTs showed intersubject variations, as well as variations across stimulating electrodes of the ABI or the CI within each subject. Behavioral GDTs were measured for one ABI electrode in S2 and for multiple ABI and CI electrodes in S5. All other subjects could not complete the task. S5 showed smaller behavioral GDTs for CI electrodes than those measured for ABI electrodes. One CI and two ABI electrodes in S5 showed comparable objective and behavioral GDTs. In contrast, one CI and two ABI electrodes in S5 and one ABI electrode in S2 showed measurable behavioral GDTs but no identifiable eACCs. Conclusions: The eACCs to temporal gaps were recorded in children with CND using either ABIs or CIs. Both objective and behavioral GDTs showed inter- and intrasubject variations. Consistency between results of eACC recordings and psychophysical measures of GDT was observed for some but not all ABI or CI electrodes in these subjects.
AB - Objectives: This study aimed to (1) establish the feasibility of measuring the electrically evoked auditory change complex (eACC) in response to temporal gaps in children with cochlear nerve deficiency (CND) who are using cochlear implants (CIs) and/or auditory brainstem implants (ABIs); and (2) explore the association between neural encoding of, and perceptual sensitivity to, temporal gaps in these patients. Design: Study participants included 5 children (S1 to S5) ranging in age from 3.8 to 8.2 years (mean: 6.3 years) at the time of testing. All subjects were unilaterally implanted with a Nucleus 24M ABI due to CND. For each subject, two or more stimulating electrodes of the ABI were tested. S2, S3, and S5 previously received a CI in the contralateral ear. For these 3 subjects, at least two stimulating electrodes of their CIs were also tested. For electrophysiological measures, the stimulus was an 800-msec biphasic pulse train delivered to individual electrodes at the maximum comfortable level (C level). The electrically evoked responses, including the onset response and the eACC, were measured for two stimulation conditions. In the standard condition, the 800-msec pulse train was delivered uninterrupted to individual stimulating electrodes. In the gapped condition, a temporal gap was inserted into the pulse train after 400 msec of stimulation. Gap durations tested in this study ranged from 2 up to 128 msec. The shortest gap that could reliably evoke the eACC was defined as the objective gap detection threshold (GDT). For behavioral GDT measures, the stimulus was a 500-msec biphasic pulse train presented at the C level. The behavioral GDT was measured for individual stimulating electrodes using a one-interval, two-alternative forced-choice procedure. Results: The eACCs to temporal gaps were recorded successfully in all subjects for at least one stimulating electrode using either the ABI or the CI. Objective GDTs showed intersubject variations, as well as variations across stimulating electrodes of the ABI or the CI within each subject. Behavioral GDTs were measured for one ABI electrode in S2 and for multiple ABI and CI electrodes in S5. All other subjects could not complete the task. S5 showed smaller behavioral GDTs for CI electrodes than those measured for ABI electrodes. One CI and two ABI electrodes in S5 showed comparable objective and behavioral GDTs. In contrast, one CI and two ABI electrodes in S5 and one ABI electrode in S2 showed measurable behavioral GDTs but no identifiable eACCs. Conclusions: The eACCs to temporal gaps were recorded in children with CND using either ABIs or CIs. Both objective and behavioral GDTs showed inter- and intrasubject variations. Consistency between results of eACC recordings and psychophysical measures of GDT was observed for some but not all ABI or CI electrodes in these subjects.
KW - Auditory brainstem implant
KW - Auditory temporal processing
KW - Electrically-evoked cortical auditory event-related potentials
UR - http://www.scopus.com/inward/record.url?scp=85055614473&partnerID=8YFLogxK
U2 - 10.1097/AUD.0000000000000498
DO - 10.1097/AUD.0000000000000498
M3 - Article
C2 - 28968281
AN - SCOPUS:85055614473
SN - 0196-0202
VL - 39
SP - 482
EP - 494
JO - Ear and hearing
JF - Ear and hearing
IS - 3
ER -